AtriCure (ATRC) Misses Q4 EPS by 13c, provides guidance
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $28.79 +1.34%
Revenue Growth %: +11.7%
Financial Fact:
Selling, general and administrative expenses: 25.49M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: +11.7%
Financial Fact:
Selling, general and administrative expenses: 25.49M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.33), $0.13 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $124.28 million versus the consensus estimate of $120.37 million.
GUIDANCE:
AtriCure sees FY2025 EPS of ($0.64)-($0.57), versus the consensus of ($0.60). AtriCure sees FY2025 revenue of $517-527 million, versus the consensus of $522.6 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- MIND Technology (MIND) Misses Q1 EPS by 5c
- Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
